Transcatheter Mitral Valve Repair Patents: Who Leads, Gaps 2026
Transcatheter mitral valve repair patents: mapping the grasping and edge-to-edge repair claim space
Concentrated at the top. the five leading assignees hold 446 of 907 records in scope (49.2%), and the leading ten hold 63.9%. Filings ran from 56 in 2017 to a peak of 117 in 2020, then eased to 54 in 2021 and 33 in 2024 — a 39% decline across that three-year window. 2025 and 2026 figures are still incomplete because publication typically lags filing by around 18 months, so the most recent years understate actual filing activity.
- 1EDWARDS LIFESCIENCES CORP123
- 2EVALVE106
- 3ABBOTT CARDIOVASCULAR SYSTEMS INC76
- 4EDWARDS LIFESCIENCES AG75
- 5MITRALIX LTD66
See the full transcatheter mitral valve repair analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on this landscape
Who holds the most patents in transcatheter mitral valve repair?
The dataset ranks 100 assignees by patent family count, and one company sits well ahead of the rest with 123 of the 907 records in scope. The gap to the fifth-ranked assignee, at 66 records, is substantial, and the top five together hold 49.2% of all records. This concentration means most of the core edge-to-edge and grasping-mechanism claim language is already occupied by a handful of device makers rather than spread thinly across the field.
Is filing activity in transcatheter mitral valve repair still growing?
No — filing peaked in 2020 at 117 records and has since declined through the last complete year of data, falling from 54 filings in 2021 to 33 in 2024, a 39% drop. That is a genuine cooling in new applications rather than market maturity or technology decline; high filing density in earlier years means the core claim space is occupied, not necessarily that the technology itself has plateaued. Figures for 2025 and 2026 are still incomplete because publication lags filing by roughly 18 months.
What technology areas dominate the patent claims?
A61F, covering implants and prostheses, appears on 75.0% of the 907 records, and A61B, covering diagnosis and surgery methods, appears on 53.5%. Because a single record can carry multiple IPC classes, these figures overlap rather than sum to 100%. Classes tied to imaging and healthcare informatics — G16H and G06T — each cover under 1% of records, marking them as comparatively under-claimed relative to the physical device and method classes.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Transcatheter Mitral Valve Repair covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.